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ABSTRACT
COMPARISON OF B-ADRENOCEPTOR COUPLED cAMP PRODUCTION IN
CULTURED HUMAN MONONUCLEAR LEUKOCYTES AND MYOMETRIAL
CELLS
by
Yu-Li Liu
B2-Adrenoceptor (B2-AR) agonists, such as terbutaline, are used as tocolytic agents in the
treatment of preterm labor. B-Adrenoceptor stimulation relaxes myometrium through
specific receptors coupled through Gs to adenylyl cyclase (AC) that catalyzes the
conversion of ATP to cAMP.
The purpose of this study was to compare B-adrenoceptors and cAMP production in
cultured human leukocytes and myometrial cells, and to determine the importance of Badrenoceptors and cAMP production in isoproterenol-induced myometrial relaxation. 125Iiodopindolol was used to assess B-adrenoceptor affinity and number. cAMP levels were
analyzed before and after stimulation by isoproterenol, A1F4‘, forskolin, and PGEt.
Isometric recording was used to examine myometrium contraction and relaxation.
B-adrenoceptors in leukocytes and myometrial cells have similar 125I-iodopindolol binding
affinity and B ,^ . Both tissues can be stimulated by isoproterenol, but have reserve
adenylyl cyclase activity not stimulated by B-ARs.
Cultured human myometrial cells have higher basal AC activity and lower isoproterenol
coupled cAMP production than leukocytes. The rank order of B-adrenoceptor agonist
potencies in leukocytes is: isoproterenol > terbutaline > ritodrine. Myometrial cells could
not be stimulated by terbutaline or ritodrine. This indicates that the intrinsic activity of Badrenoceptor coupled cAMP production is different in these two tissues.
Prolonged exposure to 200 nM terbutaline results in a decrease in both B-adrenoceptor
number and isoproterenol-coupled cAMP production in cultured leukocytes and
myometrial cells. Signal transduction factors, such as adenylyl cyclase and the PGE!
pathway, are not affected by the down-regulation process.
Isoproterenol relaxes term myometrium through B2-ARs without a change in cAMP
production.
Cultured leukocytes do not completely reflect the activity of B-adrenoceptor coupled
iii
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cAMP production to myometrial cultured cells. In myometrium, the presence o f B-ARs
does not guarantee stimulation o f cAMP production, and cAMP is not an accurate index
o f myometrial relaxation at the end of pregnancy. While leukocytes may accurately reflect
changes in myometrial B-adrenoceptors, postreceptor differences suggest that they are not
a reasonable indicator of myometrial response to B-AR stimulation.
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CHAPTER 1
INTRODUCTION

Uterine Contraction and B-Adrenoceptor Agonist Induced Relaxation
Myometrial contractions occur through two major excitation-contraction coupling
pathways: electromechanical coupling and pharmacomechanical coupling (Wray 1993).
Electromechanical coupling decreases the membrane permeability to potassium and
increases the membrane permeability to sodium. These permeability changes cause a slow
depolarization which precedes an action potential (Parkington and Coleman 1990). The
upstroke of the action potential is due predominantly to calcium entry, and the
repolarization is due to K+ efflux and inactivation o f the calcium channels (Parkington and
Coleman 1988). Pharmacomechanical coupling releases intracellular Ca2+ and modulates
the Ca2* sensitivity of the contractile regulatory apparatus through receptors (Somlyo AP
and Somlyo AV 1994). Increased intracellular Ca2+ concentration results in the formation
o f an active complex between calcium, calmodulin (CaM), and myosin light-chain kinase
(MLCK) (Barany K and Barany M 1990). Activated MLCK phosphorylates Seri 9 of the
20 kDa myosin light chain, increasing actin-activated myosin Mg2+-ATPase activity (Allen
and Walsh 1994). Myosin heads attach to actin, bind and hydrolyze ATP, reattach and
undergo transition to a force generating state, release the hydrolysis product (ADP and PJ
and again bind ATP, and repeat the contraction cross-bridge cycle (Somlyo and others
1988).
Although intracellular Ca2+ concentration is the primary regulator for the
contractile state of myometrium smooth muscle, smooth muscle contraction can also be
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2
regulated by changing calcium sensitivity, and through a calcium-independent pathway. In
rabbit portal vein permeablized with Staphylococcus aureus a-toxin, oq-adrenergic agonist
phenylephrine produced an increase in force generation when the intracellular Ca2+
concentration was sufficient for partial contraction (Gong and others 1997). This
pharmacomechanical coupling increases the calcium sensitivity o f the contractile
regulatory apparatus, such as monomeric G protein (rhoA) translocation, and inhibition of
myosin light chain phosphatase unmasks basal MLCK activity (Gong and others 1992).
Decreased Ca2+ sensitivity o f the contractile regulatory apparatus can occur if the muscle
cells are exposed to high intracellular calcium concentration. This most likely occurs
through activation of calmodulin kinase II (CaMK II) which catalyses phosphorylation of
MLCK at Ser815, increasing its calcium requirement for force generation (Tansey and
others 1992). Protein kinase C activator phorbol ester induced contractions in
permeabilized vascular smooth muscle cells from ferret aorta when calcium was -1 nM
(Walsh and others 1996). This calcium independent contraction involves the activation of
e-isozyme o f protein kinase C (PKC).
There are two physiological archetypes of myometrial smooth muscle contraction:
tonic and phasic. Pure tonic contractions respond to excitatory agonists with an active
tension and remain at that tension without visible rhythmic fluctuations in the mechanical
recording. Pure phasic contractions consist of an initial transient peak, followed by a
decline to a basal level (Somlyo AP and Somlyo AV 1994). These two types of
contraction are usually mixed in myometrium.
Oxytocin induced phasic or tonic myometrial contractions at the end of pregnancy
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3
occur through two pathways. One is through calcium influx by stimulation o f a voltagedependent and/or receptor operated calcium channel (Kawarabayashi and others 1997).
The increased intracellular calcium concentration can further induce phospholipase C
activation (Khac and others 1992). The other pathway is through the agonist-induced
receptor-Gi protein-phospholipase C cascade activation (Meldrum and others 1991;
Strakova and Soloff 1997). Phospholipase C catalyzes the hydrolysis of phosphatidyl
inositol 4,5-bisphosphate to inositol trisphosphate (IPj) and diacylglycerol. Both products
have intracellular second messenger function. Diacylglycerol stimulates protein kinase C,
whereas EP3 causes a release of Ca2+ from intracellular stores. The contractile effects of
oxytocin can be inhibited by nifedipine or ruthenium red, an inhibitor o f Ca2+-induced
calcium release (Phillippe and Basa 1996, 1997).
Myometrial contraction can be potently inhibited by B-AR agonist isoproterenol.
Its mechanism of action is mainly through increasing intracellular cAMP which activates
cAMP-dependent protein kinase (A kinase) and phosphorylates myosin light chain kinase
(MLCK), resulting in inhibition of MLCK from activation by Ca2+-calmodulin (Torphy
1994). Other than this central pathway, Khac and others (1996) found an alternate
isoproterenol relaxant pathway in pregnant rat myometrium that is linked via a cAMPindependent, pertussis toxin-sensitive process to activation o f K* channels. The activated
K+ channels hyperpolarize the membrane, inhibit voltage-operated Ca2+ channels and
induce a decrease in calmodulin activation (Biilbring and Tomita 1969; Kroeger and
Marshall 1973, 1975). Ishine and others (1993) reported another pathway by examining an
isoproterenol-induced relaxation o f Wistar rat uterus in Ca2+-free solution. They conclude
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Figure 1. KC1- and oxytocin-initiated myometrial contraction and fl-adrenoceptor-induced
relaxation mechanisms.

that isoproterenol inhibits Ca2+-free myometrial contraction through a Br AR mediated
cAMP pathway and K+ stabilization, and through a pathway which could not be blocked
by phentolamine, timolol, or butoxamine.

B-Adrenoceptor Subtvpes and Uterine Relaxation
B-AR subtypes may contribute differently to myometrial relaxation at the end of
pregnancy. Since isoproterenol stimulates adenylyl cyclase through both Br and B2-AR
subtypes via an intermediate G protein (Gs), binding of either receptor subtype may
activate adenylyl cyclase resulting in uterine relaxation (Wray 1993). Several studies
indicate different expression of B-AR subtypes at the end o f pregnancy. In pregnant rat
myometrium, Maltier and others (1989) found the number of B2-AR decreases from
gestation day 18 (433 fmole/mg protein) to day 21 (229 fmole/mg protein). The receptor
number was constant between gestation days 21 and 22, but during the six hours before
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5
parturition, decreased markedly (58.7 fmole/mg protein). B2-AR mRNA decreases linearly
throughout the gestational period from day 0 to day 21 (Engstrom and others 1997). Five
days after parturition, B2-AR mRNA increases 8 fold as compared to gestation day 21.
However, Principe and others (1997) using quantitative reverse transcriptase-polymerase
chain reaction technique observed a gradual decline in rat Br AR mRNA levels from day
12 o f gestation through postpartum day 1; in contrast, B2-AR mRNA levels remained
stable, except for a variable nadir on the day o f parturition (day 22). B2-AR selective
agonist salbutamol is more potent in its inhibitory effect on rat spontaneous uterine
contraction at the end of pregnancy than at the middle of pregnancy (Chemaeva 1984).
There is no change during pregnancy in the inhibition of spontaneous uterine contractions
by non-selective B-AR agonist isoproterenol (Chow and Marshall 1981). In human
myometrium, Dattel and others (1986) found no change in B-ARs from women in labor or
before labor between 28 and 34 weeks of gestation. They did not further analyze changes
in receptor subtype. These results indicate the importance of examining human B, and B2AR coupled myometrial response at the end of pregnancy.

Therapeutic Dosages and Limitations of B,-Agonists
Preterm labor is defined by uterine contractions that develop between 20 and 37
weeks gestation with progressive cervical dilation or effacement or both (Graf and PerezWoods 1992). Preterm labor occurs in 7-8% of all births in the United States and accounts
for a disproportionate percentage of perinatal, neonatal and infant morbidity and mortality
(Caritis and others 1988). The cause of preterm labor is unknown. The tocolytic B2-AR
agonists terbutaline and ritodrine, are commonly used in patients experiencing preterm
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labor because B2-AR agonists produce uterine relaxation with minimal direct cardiac Br
AR side effects (Berg and others 1982). These tocolytics can delay delivery for 48 hours.
However, B2-AR agonists are not without disadvantages. These agents are B2-selective,
but at high concentrations stimulate Br ARs and induce tachycardia. Cardiovascular side
effects limit the dose and effectiveness of B2-AR agonists as uterine relaxants (Doggrell
1995). Continuous exposure to tebutaline or ritodrine produces a loss of uterine relaxation
at therapeutic concentrations (Ryden and others 1982; Caritis and others 1987). Use of 82AR agonists since 1980 has not improved the rate of preterm delivery (Macones and
others 1995).

Leukocytes as Receptor-cAMP Index of Less Accessible Uterine Tissue
Although the functional response of leukocytes to B-AR stimulation has not been
studied extensively, B-ARs may be involved in modulation of immune response.
Isoproterenol can block the expression of interleukin-2 receptors on human T lymphocytes
(Feldman and others 1987). Interleukin-2 receptor expression and stimulation promotes T
lymphocyte blastogenesis, clonal expansion, and differentiation. Furthermore, stimulation
by B-AR agonists may selectively regulate specific lymphocyte subsets (Landmann 1992).
Acute sympathetic activation by adrenaline infusion causes a selective increase in
circulating CD56+ or CD57* natural killer lymphocytes which are rich in B-ARs. This
selective immunomodulatory effect is probably a consequence of an elevation in
intracellular cAMP. Knudsen and others (1995) correlated isoproterenol-stimulated cAMP
production with lymphocyte subset composition in mononuclear cells isolated from resting
human subjects and found NK-cells (CD3\ CD56+) and T cytotoxic cells (CD8+) produced
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greater amounts of cAMP than T helper cells (CD4*) and B-lymphocytes (CD 19*,
CD2(T).
Leukocyte B-ARs have been correlated to different tissues or diseases in order to
create an index for B-ARs in less accessible tissues (Connolly and others 1992; Zoukos
and others 1994). In human myometrium, Michel and others (1989) simultaneously
determined the density of B-ARs in human myometrium and lymphocytes derived from 36
women undergoing cesarean section. The density of both myometrial and lymphocyte BARs was about 65-70% lower in women treated with the B2-AR agonist hexoprenaline for
preterm labor compared to untreated women. The isoproterenol-evoked increase in
lymphocyte cAMP content (as an index for lymphocyte B-AR responsiveness) was
diminished to a similar extent in hexoprenaline treated women. Michel and others (1989)
found a significant positive correlation between myometrial and lymphocyte
beta-adrenoceptor densities (r = 0.7303; n = 36; p less than 0.001), and suggested that
determination of beta-adrenoceptor number in circulating lymphocytes may be a useful
model to monitor myometrial beta-adrenoceptor changes during tocolytic therapy. Berg
and others (1984) correlated cAMP production between myometrial tissue and leukocytes
in 21 women delivered by Cesarean section for obstetrical reasons. After in vitro B-AR
stimulation, cAMP production was closely correlated between the two tissues (r = 0.96).
However, myometrium membrane preparations can include membranes from different cell
types, such as blood cells, endothelial cells, and connective tissue and may not represent
intact pure myometrial cells. The purpose of the current investigation was thus to compare
B-ARs and cAMP production in cultured intact leukocytes and myometrial cells.
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B-Adrenoceptors
Ahlquist (1948) distinguished B-ARs from a-ARs based on the relative potencies
of five phenethylamines (norepinephrine, epinephrine, a-methylnorepinephrine, amethylepinephrine, and isoproterenol). Responses for isoproterenol, such as relaxation of
peripheral blood vessels, relaxation of the uterus, and stimulation of cardiac rate and force,
were designated as B-adrenergic. Lands and others (1967a, 1967b) proposed the presence
o f two B-AR subtypes, named 6,- and B2-ARs. This divides B-AR responses generated by
the neuronally- released norepinephrine from hormonal circulating epinephrine. Currently,
a third subtype o f B-AR, B3 is known to be functionally expressed in mammals (Strosberg
1993).
B-ARs have been purified to homogeneity from mammalian tissues and determined
to be a single polypeptide chain o f 62,000-67,000 Da (Lefkowitz and others 1983;
Benovic and others 1984; Cubero and Malbon 1984). Hydrophobicity analysis of the
primary amino acid sequence of the B-AR indicates a pattern of seven repeating
hydrophobic clusters (Dixon and others 1987; Dohlman and others 1987b; Lefkowitz and
Caron 1988). The highest degree o f amino acid homologies are retained in the
hydrophobic sequences, while diversity is observed in the sequences of the N- and Ctermini. In the extracellular loops, specific cysteines are conserved (Dohlman and others
1987b; Malbon and others 1987), which may form disulfide bridges. In the hydrophobic
helices, proline and glycine residues are retained (Strader and others 1987; Dixon and
others 1988). These residues could be expected to cause kinks or bends in the helical
structure. Potential N-linked glycosylation sites are present in the amino-terminal
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segments of these receptors (Dohlman and others 1987a). Dohlman and others (1987a)
and Wong and others (1988) using structurally distinct and selective B-AR photoaffinity
probes demonstrated covalent labeling only in the hydrophobic transmembrane regions.
Extensive treatment with protease had little effect on either agonist or antagonist binding
to B-AR (Dohlman and others 1987a; Rubenstein and others 1987). Hydrophilic sequences
appear to be less important for the integrity o f functional coupling; thus, deletion of these
segments had very little effect on ligand-binding. Together, these findings indicate that the
ligand-binding site o f the B-AR exists within the hydrophobic core composed of the seven
transmembrane-spanning elements.
Human mononuclear leukocyte B-AR were first studied using radioligand binding
o f B-AR antagonist 3H-alprenolol by Williams and others (1976). Using homogenized cell
membranes, they found a receptor density o f 75 ± 12 fmol/mg protein, corresponding to
about 2,000 sites/cell. The B-AR density evaluated by binding study may vary due to many
reasons. Hydrophilic radioactive ligands might only measure the cell surface B-ARs.
Motulsky and others (1986) found acute exposure to isoproterenol internalized the cell
surface B-ARs and decreased the binding o f hydrophilic B-AR antagonist [3H]CGP-12177
in intact leukocytes. Use o f tritiated ligands also has the disadvantage of low specific
radioactivities and thus a large number o f cells may be required. Hydrophobic ligands l25Icyanopindolol or 125I-iodopindolol are also used to assess intracellular and extracellular
receptors (Thede-Reynolds and others 1986; von Mandach and others 1993). B-AR
binding can also be influenced by preparation o f cells or membranes, incubation
temperatures, and other binding conditions. Additionally, Landmann (1992) suggested
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differences in B-AR number between leukocyte subpopulations. These conditions should
be considered when comparing the results between different tissues or studies.
Hayashida and others (1982) found that beta-adrenergic antagonist [3H]
dihydroalprenolol (DHA) binds to particulate preparations o f human myometrium with a
Kd of 0.50 nM and a

of 70 fmoles/mg of protein. In human myometrium, the number

o f ctj- and Bj-adrenergic receptors increase concomitantly with circulating plasma estradiol
levels (Bottari and others 1985). This effect is counteracted by progesterone. Engelhardt
and others (1997) compared 14 pregnant patients who had received B-AR agonist
fenoterol and 14 untreated pregnant controls and found a decrease in B-ARs, but not in
mRNA, Gs, Gi, or B-AR kinase activity following B-AR agonist fenoterol treatment.
The development of radioligand-binding techniques and adenylyl cyclase assays
have greatly facilitated the subclassification of the B-ARs and the assessment of the tissue
distribution of the Br , B2-, and B3-AR subtypes. In receptor binding studies, Br and B2ARs have shown a wide distribution and a colocalization in almost all tissues (Hieble and
Ruffolo 1991). The B3-AR is found in both white and brown adipocytes in human, and
mediates norepinephrine-induced lipolysis (Strosberg 1995). Whether the B3-AR is
involved in other physiological roles remains a point for future investigation. No B3-AR
have yet been reported in brain, leukocytes or uterus.
The colocalized subtypes of B-ARs are often characterized using displacement of
radioligand binding by an unlabelled compound (Brodde and others 1983; Breuiller and
others 1987; Beer and others 1988). If the compound has a selective binding affinity (KD)
for each receptor subtype, the heterogeneous population of receptor subtypes will be
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measured. Highly selective antagonists have been used to analyze the colocalization of
receptor subtypes. At the 6 , and B2-AR, CGP-20712A and ICI-118551 are potent
antagonists, with KDvalues below 1 nM and subtype selectivity o f greater than 100 fold
(Bilski and others 1983; Lemoine and others 1985; Molenaar and Summers 1987).
Analyzing the displacement o f radioligand by Br or B2-AR antagonists can provide an
estimation of the percentage o f Br and B2-sites in a particular tissue preparation (Hieble
and Ruffolo 1991).
Agonist and antagonist selectivities at the binding domains of B-ARs have been
evaluated in different receptor subtypes. Frielle and others (1988) synthesized a number of
chimeric DNAs which were constructed by substituting various domains of the seven
transmembrane Bj-AR for their counterparts in the B2-AR. The chimeric B^B^ARs were
expressed in Xenopus laevis oocytes and assayed for agonist- and antagonist- radioligand
displacement. The results suggest that subtype specificity is determined by most of the
transmembrane regions of the molecules. This supports the idea that binding of ligands by
B-ARs occurs in a pocket formed by the membrane-spanning a-helices.

G Proteins
G proteins are heterotrimers composed of a, B, and y subunits. The a-subunit
defines an individual G protein oligomer. The B- and y-subunits exist as a tightly
associated complex that functions as a unit. The same By subunit complex can be shared
among different a-subunits to form the heterotrimer. The a-subunits have a single high
affinity binding site for guanine nucleotides (GDP or GTP). The GDP-bound form of a
binds tightly to By and is inactive; on the other hand, the GTP-bound form o f a dissociates
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from By and serves as a regulator of effector enzymes. Aluminum tetrafluoride (A1F4*),
together with Mg2*, interacts with GDP to mimic GTP and, thereby, activates Ga (Hepler
and Gilman 1992). The G protein a-subunit can further be divided into four major
subfamilies: Gs, Gi, Gq, and G12. Receptors like B-AR interacting with the Gs family
stimulate AC; receptors such as c^-AR interact with the Gi family and inhibit AC; and
receptors such as a,-AR interact with the Gq family and activate phospholipase C-B (PLCB) (Hepler and Gilman 1992). Although the effector for the G12 family has not been well
defined, Na+-H* exchanger is regulated by G12 (Lin and others 1996).
G proteins are widely distributed in all tissues (Kaptein and others 1995). In human
mononuclear leukocytes, including lymphocytes and macrophages, G proteins are coupled
not only to B-ARs, but also to other similar seven-transmembrane receptors, such as those
for chemoattractants C5l, platelet-activating factor, and interleukin 8 (IL-8 ) (Gerard C and
Gerard NP 1994; Murphy 1994). This suggests the involvement o f G proteins in the
regulation o f acute and chronic inflammation (Murphy 1994).
In myometrium, Cohen-Tannoudji and others (1995) using immunoblot and
hybridization blot analysis found that estradiol had significantly increased the levels of both
Gi2a subunit and Gi2a mRNA at the end of pregnancy. Gqa protein and mRNA were
also significantly lower at midpregnancy under progesterone dominance compared with
term. These results demonstrate that myometrial Gi2a and Gqa subunits are physiological
targets for estradiol and progesterone, respectively, in vivo. Alterations of these G protein
levels are related to their mediating effects on adenylyl cyclase activity or the
phospholipase C pathway during the course of pregnancy. Lopez-Bemal and others
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(1995) suggested that pregnancy is associated with changes in G-protein signaling and
second messenger formation in human myometrium. During gestation, uterine relaxation is
favored by a pronounced increase in cAMP formation. The change in Gas is reversed in
spontaneous labor, enabling the uterus to become responsive to contractile agents.

Adenvlvl Cvclase
The enzyme adenylyl cyclase (AC) functions as an effector molecule that transfers
the signal of activated B-AR through Gas to a cellular response. This enzyme catalyzes the
formation o f cyclic 3',5-adenosine monophosphate (cAMP) from ATP. Cloning studies
have identified at least eight different types of AC (Krupinski and others 1989; Mons and
Cooper 1995). All known AC species can be directly stimulated by forskolin, a diterpene
isolated from the roots of the aromatic herb Coleusforskohlii (Seamon and Daly 1981).
This has greatly aided the isolation and purification o f AC from the heart and brain by
means o f affinity chromatographic techniques (Coussen and others 1985; Pfeuffer and
others 1985; Yeager and others 1985; Smigel 1986).
AC consists of a single glycoprotein chain with a molecular weight of -150,000 Da
(Pfeuffer and others 1985; Smigel 1986). It encodes the topology of tandem repetition of
a hydrophobic putative transmembrane domain that spans the membrane six times and a
large hydrophilic cytoplasmic domain (Gao and Gilman 1991). Based on amino acid
sequence similarities, the subtypes of AC have been classified into three subfamilies: the
type I-like group (subtypes I, HI, and VIII); the type 0-like group (subtypes O, IV, and
VO); and the type V-like group (subtypes V and VI) (Tang and Gilman 1992; Iyengar
1993; Cali and others 1994; Taussig and Gilman 1995). These subfamilies share certain
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functional properties, although each individual subtype displays a unique response to
different stimuli (Bourne and Nicoll 1993; Anholt 1994; Cooper and others 1995; Taussig
and Gilman 1995). Each AC can be regulated by a subunits o f a G protein (Tang and
Gilman 1992; Iyengar 1993), except the type I-like group which is refractory to
stimulation by Gas (Tang and others 1991), and the type II-like group which is refractory
to inhibition by Gai (Taussig and others 1994). These diverse modes of regulation result
in more regulatory options in tissues containing AC. The subtypes o f AC in leukocytes
have not been defined. In myometrium, Kumasaka and others (1996) used reverse
transcriptase and polymerase chain reaction methods to identify the appropriate molecular
weights for AC subtypes HI, IV, V, VI, and VTII from rat myometrium. This suggests that
complex interactions with multiple signal transduction pathways might exist in uterine
smooth muscle.

Desensitization and Down-Reeulation o f 0-Adrenoceptors
Continuous exposure of B-ARs to an agonist often leads to an attenuation of signal
transduction. This agonist-induced process is called desensitization, refractoriness, or
tolerance (Nijkamp and others 1992). Desensitization can be broken down into rapid and
delayed processes (Stiles and others 1984; Dohlman 1991). Rapid desensitization is
characterized by the attenuation of signaling within seconds to minutes o f exposure to the
agonist, and a rapid recovery even in the absence of protein synthesis (Dohlman 1991).
There are two major patterns of rapid desensitization, referred to as homologous and
heterologous desensitization (Lefkowitz and others 1980).
Homologous desensitization is a phenomenon which is receptor specific, such as
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that affecting only B-ARs (Lohse and others 1990). Homologous desensitization o f B-ARs
is a multistep process associated with uncoupling o f receptors from G-protein and
phosphorylation by B-AR kinase, which translocates from cytosol to membrane during BAR stimulation (Strasser and others 1986). B-Arrestin is required to effect the
homologous desensitization triggered by agonist occupancy and B-AR kinase
phosphorylation o f the receptor (Collins and others 1991). Another is a sequestration of
the receptor away from the plasma membrane. Sequestration acts as a mechanism for the
dephosphorylation o f the receptor, which allows subsequent resensitization (Sibley and
others 1986).
Heterologous desensitization is a process whereby activation o f one type o f
receptor causes the desensitization o f other types of receptors as well (Lohse and others
1990). Heterologous desensitization does not usually involve receptor sequestration and
appears to be mediated by cAMP. Therefore, prostaglandin E,, which stimulates
prostaglandin receptors and increases the cAMP level, can be used as a measure of
heterologous desensitization occurring after B-AR stimulation. Nevertheless, heterologous
desensitization shares a similar pathway as homologous desensitization in receptor
phosphorylation and impairment o f AC activation (Dohlman 1991; Nijkamp and others
1992).
Delayed desensitization or down-regulation is characterized by a decrease in the
total number of B-AR with an accompanying loss in effector stimulation over hours to
days o f agonist treatment, and the requirement for de novo protein synthesis for recovery
o f receptor number (Hausdorff and others 1990; Dohlman 1991; Von Zastrow and
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Kobilka 1992). Two pathways have been hypothesized for down-regulation. One is an
acceleration o f receptor degradation, presumably in lysosomal vesicles. Another is the
decrease in receptor biosynthesis (Morishima and others 1980; Doss and others 1981;
Wakshull and others 1985). The first pathway was studied by Von Zastrow and Kobilka
(1992). They found the cellular pathway and compartments that mediated the
internalization o f ARs through a endosome recycling process. As diagrammed in Fig. 2,
receptor internalization (arrow A) can occur at a substantial rate without intracellular
accumulation o f receptors, pro viding that the recycling rate (arrow B) is comparably
rapid. Nevertheless, this receptor internalization and recycling traffic can be sufficient to
supply a degradative pathway from endosome to lysosome (arrow C). This contributes to
the down-regulation o f receptors in the absence of marked sequestration. By manipulating
the relative rates o f the individual steps (represented by the arrows), the cell could
independently regulate receptor sequestration (accumulation in endosomes at steady state)
and down regulation (sorting of a portion of receptors passing through endosomes to
lysosomes). Prolonged exposure to either B-AR agonists or cAMP analogs produced a
loss o f receptor binding sites, accompanied by substantial decreases in B2-AR mRNA
levels (Hadcock and Malbon 1988; Collins and others 1989).

Statement of the Problem
The presence o f B-ARs in human mononuclear leukocytes and myometrial cells has
been established (Williams and others 1976; Motulsky and Insel 1982). It is conceivable
that the function or interaction between B-ARs, Gas, and AC may play an important role
in regulating the signal transduction process (Nijkamp and others 1992). B-ARs in
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Endosome Sorting

Lysosome
Degradation
Figure 2. Proposed model of cellular pathways mediating sequestration
and down-regulation of B-ARs.

circulating mononuclear leukocytes have been used as an index for assessing B-AR
function in less accessible tissues in humans (Motulsky and Insel 1982; Brodde and others
1987). Berg and others (1984) and Michel and others (1989) compared B-AR density and
cAMP production in human leukocytes and membrane preparations of human
myometrium and suggested that the tissues reflea one another. In order to explore the
similarity between human myometrium and leukocytes, the hypothesis is established that
similar B-AR and coupled cAMP produaion is present in cultured human mononuclear
leukocytes and myometrial cells.
Since B, and B2-ARs coexist in human myometrium and both receptor subtypes
couple Gs protein and stimulate adenylyl cyclase, it is possible for both receptor subtypes
to contribute to isoproterenol-induced relaxation during pregnancy. Results from rat
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uterus have generated controversies concerning receptor subtypes at the end o f pregnancy,
Maltier and others (1989) and Engstrom and others (1997) found a decrease in both B2AR protein and mRNA levels, while Principe and others (1997) found a decreased at
mRNA for Bt-AR but not B2-AR. B2-AR selective agonist potently inhibits rat uterine
contraction which suggests a predominant function of B2-AR at the end of pregnancy
(Chemaeva and others 1984). In human, the contribution of Br AR in relaxation o f uterine
tissue has not been investigated. Therefore, the second hypothesis is established that there
is a proportional contribution from Br and B2-ARs in the isoproterenol-induced human
myometrial relaxation at the end o f pregnancy.

Aim of the Study
This study compares B-ARs and cAMP production in human mononuclear
leukocytes and cultured myometrial cells, and examines the receptor subtypes involved in
isoproterenol-induced myometrial relaxation. Experiments were designed to assess the
effect of terbutaline treatment on receptors and cAMP production, and isoproterenolinduced myometrial relaxation. The experimental goals of the study include:

1. To establish experimental conditions for the isolation and culture of human leukocytes
and myometrial cells, and measurement of B-AR binding, cAMP production and
myometrial relaxation.
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2. To compare B-AR properties and cAMP production between cultured leukocytes and
cultured myometrial cells, and assess alterations produced by exposure to B2-AR agonist
terbutaline.

3. To determine the contribution o f Br and B2-AR subtypes in isoproterenol-induced
myometrial relaxation.
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CHAPTER 2
MATERIALS AND METHODS

Protocols using tissue from consenting adults were approved by the Institutional
Review Boards of East Tennessee State University and the Johnson City Medical Center.
All reagents were purchased from Fisher (Pittsburgh, PA) unless otherwise noted.

Relaxation Study of Human Myometrium

Preparation of Uterine strips
Uterine tissue was collected at the Johnson City Medical Center from HIVseronegative women (age 19 to 39 years) requiring cesarean delivery at 39-40 gestational
weeks. Isolated uterine muscle strips were prepared using a modification of the method of
Word and others (1992). Myometrial biopsies obtained from women requiring caesarean
section were transported in oxygenated physiological salt solution (NaCl, 120.5 mM; KC1,
4.8 mM; CaCl2-2H20 , 1.6 mM; MgCl2 -6H20 , 1.2 mM; NaHC03, 20.4 mM; NaH2P 0 4 H 20 , 1.2 mM; Dextrose, 10 mM; pyruvate, 1 mM, pH 7.4), maintained at room
temperature. Tissues were immediately dissected into strips longitudinal to the muscle
fibers with a dimension approximately 1 x 0.2 x 0.2 cm and were mounted in 12 ml organ
baths containing physiological salt solution (PSS) at 37°C. One end of each strip was
attached to a fixed hook, the other end to an FT03C isometric force displacement
transducer (Grass Model 7D polygraph, Quincy, MA). After mounting, a recovery period
of 2 hrs was allowed until a stable baseline has achieved. The buffer in the organ baths was
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replaced with prewarmed PSS solution at least every 30 min, and continuously aerated
with a mixture of 95% 0 2 and 5% C 0 2.

Leneth-Tension and Relaxation Response
The myometrium muscle strip was maintained at a resting tension o f 1000 mg.
Optimal resting tension was determined by contracting tissues with 65 mM KC1 and
adjusting resting tension to achieve maximal contraction. A KC1 concentration of 35 mM
was chosen for producing sustained contraction and greatest isoproterenol relaxation.
Subsequently, cumulative concentrations of isoproterenol were added to relax the strips in
the presence of 35 mM KC1. Washout and re-equilibration (minimum 80 min) separated
sequential exposure to isoproterenol in the absence and presence of 0 .1 pM ICI-118551
((±)-1-[2,3-dihydro-7-methyl- lH-inden-4-yl)oxy]-3-[( 1-methylethyl)amino]-2-butanol
hydrochloride, Research Biochemicals International, Natick, MA), or 0 .1 pM CGP20712A ((±)-2-Hydroxy-5-[2-[[2-hydroxy-3-[4-[ 1-methyl-4-(trifluoromethyl)- 1Himidazol-2-yl]phenoxy]propyl]amino]ethoxy]-benzamide methanesulfonate, Research
Biochemicals International, Natick, MA). Tissues were pre-exposed to selective B-AR
antagonists for at least 80 min. The detail experimental design is shown in Fig. 3.

Quantification of Contractile and Relaxation Response
Responses to individual isoproterenol concentrations were measured as the
maximum relaxation occurring 5 to 10 min after exposure. Comparisons of relaxation
between tissues tested with isoproterenol, isoproterenol in the presence of ICI-118551 or
isoproterenol in the presence of CGP-20712A were made by normalizing tissue responses
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Figure 3. Experimental design for isoproterenol-induced relaxation.

between the KCl-induced contraction at 10 min (100%) and resting tension (0%). The
average tissue weight was 46.9 ± 2.3 mg (n=8 ). The cross-sectional area (square
centimeters) of each tissue was determined by the following formula: W/(LxD), where W
is the wet weight of tissue in grams, L is the stretched length in centimeters, and D is
tissue density (1.05 g/cm3). The average cross-section was 0.031± 0.002 cm2 (n= 8 ), the
average stretched tissue length was 1.45 ± 0.035 cm (n= 8 ), and the average tissue width
was 1.75 ± 0.041 mm (n=8 ). The percentage relaxation at varying concentrations o f
isoproterenol was resolved by nonlinear least-squares curve fitting to the following
equation using GraphPad Prism (San Diego, CA) to give the minimum and maximum
relaxation as well as the ECjo value for each experiment.
n ,
....
... .
Relaxations/a) = Minimum *

Maximum-Minimum
1

+

io 00®^50 " h*VmProUrm,cb
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The pKB of ICI-118551 was calculated for individual tissues from the dose ratio (dr) of
isoproterenol concentrations producing 15% relaxation in the presence and absence of
ICI-118551 using the following relationship:
p K a = log(dr-l) - log[/C /-118551]

Human Mononuclear Leukocytes Isolation and Culture
Mononuclear leukocytes were isolated by a modification o f the method of Boyum
(1968), but were maintained at 4°C during isolation to inhibit alterations in leukocyte (5*

adrenoceptors. Heparinized whole blood (143 units/ 10 ml) was removed by venipuncture
from healthy male volunteers (age 25 to 42 years). Blood from female volunteers was used
only for preliminary experiments. Blood was diluted with an equal volume of DPBS
containing 10 mM Ca2\ 10 mM Mg2* (Sigma, St. Louis, MO) and layered onto
Histopaque-1077 (Sigma). After separation by centrifugation at 400xg for 40 min, the
layer containing mononuclear leukocytes was removed and washed three times with DPBS
by pelleting at 400g for 10 min. The freshly isolated cells were counted in a
hemocytometer.
Cell viability was evaluated by trypan blue exclusion. A sample of each cell
suspension was mixed with an equal volume of 0.4% trypan blue in DPBS solution. The
mixed cell suspension was transferred to the edge o f the coverslip and was allowed to run
into the counting chamber of the hemocytometer. The total number of cells and the stained
cells were counted separately. Cells excluding dye were considered viable. The percentage
o f living cells was greater than 90% when assessed by this method.
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Freshly isolated leukocytes were resuspended in DPBS for assay of B-ARs and
cAMP production or were incubated in a 25 cm2 stand-up flask at 37°C with 95% air- 5%
C 0 2 for three days in RPMI-1640 medium containing 20% FCS (HyClone, Logan, UT)
and 1% antibiotic antimycotic solution (Sigma). After three days of incubation, the
leukocytes were centrifuged at 400xg for 10 min and washed twice with DPBS buffer.
The incubated cells were resuspended in the same DPBS buffer for further assay.

Human Myometrial Isolation and Cell Culture
Uterine samples were obtained from the upper transverse incision at the lower
anterior uterine wall (outer layer) and were cultured using a slight modification of the
method of Casey and others (1984). Immediately after surgery, a small specimen of
myometrium was placed in ice-cold DPBS containing 10% antibiotic antimycotic solution.
Myometrium was washed and cut to ~ 1 mm3 pieces in DPBS containing 10%
antibiotic antimycotic solution and transferred to DPBS containing 2% antibiotics and
0.25 mg/m1 collagenase Type II (from Clostridium histolyticum\ Worthington
Biomedicals, Freehold, NJ). The preparation was disaggregated by agitating for 16 hrs at
37° C in an incubation bath and filtered through four layers of gauze to remove
nondispersed tissue fragments. The filtrate was centrifuged at 600xg for 10 min at 4°C
and washed with culture medium DMEM-F12 containing 10% FCS. The cells were grown
in T7J flasks to confluence in a 95% air-5% C 0 2 incubator at 37°C with biweekly medium
changes. Confluent cells were detached by treatment with 5 ml of 0. 1% trypsin, 0.25%
EDTA in Ca2+, Mg2+-free DPBS at 37°C incubator for 5 min. After the cells were

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

25
detached, 5 ml of 10% FCS containing DMEM-F12 medium was added to neutralize the
trypsin. The cell suspension was centrifuged at 600xg for 10 min, washed twice by DPBS
buffer and resuspended in the same buffer for further assay. Cell number and viability were
analyzed by hemocytometer and trypan blue exclusion. Cultured myometrial cells were
used within seven passages.

Myometrial Smooth Muscle Cell Identification
Myometrial cells were identified using a fluorescent specific filamentous actinbinding toxin, 7-diethylamino-3-(4-isothiocyanotophenyl)-4-methylcoumarin (CPITC)phalloidin (Sigma). Cells cultured in a two well chamber slide were fixed in DPBS
containing 3.7% formalin, washed with DPBS and dried by air. Fixed cells were incubated
with CPITC-phalloidin (final concentration 0.05 mg/ml in DPBS) for 20 min at room
temperature, washed twice with DPBS, mounted in 30% glycerol and viewed with a
fluorescent microscope using UV light and filter 475 BG3 (Olympus BH model).

Tissue. Disaggregated Cell, and Culture Cell Membrane Preparation
Myometrial tissue, disaggregated cells or detached 24 hrs cultured cells were
washed, minced on ice (tissue), suspended in 50 mM Tris-HCl (pH7.4) 0.25 M sucrose
buffer, and homogenized using a Tissumizer (Tekmar; Cincinnati, OH) for 1 min at
maximum speed. Tissue homogenates were filtered through three layers o f gauze.
Homogenates were centrifuged at 600xg for 10 min at 4°C. The supernatant was
collected, the pellet was resuspended and homogenized in Tris-sucrose buffer and
centrifuged at 600xg for 10 min at 4°C. The two supernatants were combined and
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centrifuged at 105,000xg (35,000 rpm) for 60 min at 4°C in a Beckman (Palo Alto, CA)
model L5-65B preparative ultracentrifuge with a 50.2 Ti rotor. The final pellet containing
the membrane fraction was suspended in 50 mM Tris-HCl (pH7.4). Protein concentration
was measured by the method of Bradford (1976) and the volume adjusted to give
appropriate protein concentration.

B-Adrenoceptor Saturation Binding Study
Intact freshly isolated leukocytes, incubated leukocytes or myometrial cells were
incubated at 37°C in a 96-well Multiscreen GF/C glass fiber plate. The assay volume (0.2
ml) contained 4x10s leukocytes or 2x10s myometrial cells and 2.5 to 600 pM
concentrations of radioligand [l2SI]-(-)-iodopindolol (from New England Nuclear, Boston,
MA) in DPBS. Following equilibration for 30 min (leukocytes) or 60 min (myometrial
cells), the mixture was filtered and washed three times with 0.25 ml of ice cold 25 mM
MOPS (3-[N-morpholino]propanesulfonic acid) buffer (pH 7.4) using a Vaccu-pette/96™
(DBM Scientific, Valencia, CA). Filters containing radioligand were counted in a
Beckman Gamma 7000 gamma counter.

Saturation Binding Data Analysis
The 12SI-iodopindolol - p-adrenoceptor dissociation constant (KD) and Padrenoceptor density ( B ,^ ) were estimated by weighted (Y*2) nonlinear least squares
regression using GraphPAD Inplot (San Diego, CA). A model for one specific receptor
binding site plus linear nonspecific binding (KNONSPEaFIC) was used:
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Curve fitting resolved total binding into specific binding to B-adrenoceptors and
nonspecific binding. The KD is the dissociation constant for 125I-iodopindolol, the Bmax is
the maximum specific binding, and the KNONSPEaFIC is the nonspecific binding constant.
After similar values appeared repeatedly at 33.3 pM, the program LIGAND (Biosoft,
Cambridge, UK) was used to fix I25I-iodopindoloI KDin down-regulation experiments for
estimation o f B ^ ^ for individual patients (Munson and Rodbard 1980).

B-Adrenoceptor Displacement Binding Study
Resuspended intact leukocytes and myometrial cells were incubated with a fixed
concentration of 125I-iodopindoIol between 70-120 pM. The cell number, buffer and
incubation time were the same as those for saturation binding. B-AR antagonist ICI118551 was incubated at varying concentrations with each cell type. After incubation, the
buffer was immediately vacuumed through GF/C glass fiber filters and washed three times
with 0.25 ml of ice cold 25 mM MOPS buffer which was applied using a Vaccupette/96™ (DBM Scientific, Valencia, CA). The radioactive filters were punched out and
the retained radioactivity measured by a Beckman Gamma 7000 counter.
The membrane preparation of myometrial tissue, disaggregated cells, or 24 hrs
cultured cells used to measure total and B-AR receptor subtypes was modified from
Nimmo and others (1995) and Breuiller and others (1987). Cell membranes from each
group containing (final concentration) 50 pg protein were incubated for 1 hr on a
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Multiscreen GF/B filter plate with 35 pM o f I23I-iodopindolol in 200 pi o f 50 mM TrisHCl pH 7.4, 5 mM MgCl2, 154 mM N a d , 1 mM ascorbic acid, and 0 . 1% bovine serum
albumin at 37°C. Samples were filtered by vacuum, washed three times with 0.25 ml cold
washing buffer (50 mM Tris-HCl pH 7.4, 5 mM MgCl2, 154 mM NaCl, 1 mM ascorbic
acid) and the retained radioactivity measured by a Beckman Gamma 7000 counter.
Non-specific binding was determined by incubating I23I-iodopindolol in the
presence o f 1 pM (-)-propranolol. ICI-118551 (0. 1 pM) or CGP-20712A (0 .1 pM) were
used to selectively block B2-ARs or B,-ARs respectively (Molenaar and Summers 1987;
Molenaar and others 1988).

Displacement Binding Data Analysis

In intact cells. The K,, and

are the dissociation constants of ICI-118551 at Br

and B2-adrenoceptors respectively. The dissociation constants were derived from the IC^
values obtained from the following equation:
{Max -Bottom)*{fraction.)
{Max -Bottom ) *(1 -fraction.)
Binding = Bottom + --------------------------------- +■-------------------------------------

[ i + i o ^ '00^
The binding was resolved by curve fitting into two specific displacement binding sites to
B-adrenoceptors and nonspecific binding (Bottom). The “Max” is the maximum total
binding in the absence of competing drugs, the “Bottom” is the nonspecific binding,
“fraction," is the fraction of Br adrenoceptors, and the remaining specific binding “ 1fraction," is the fraction o f B2 adrenoceptors, the “F is the Log o f the antagonist
concentration, and the IC50, or IC502 are the concentrations displacing 50% o f binding to

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

29
B,- or 02-adrenoceptors. The Kj! and

are transformed from the respective IC50 using

the Cheng and Prusoff (1973) relationship,
K = _______ IC50
' j t [1251 -Iodopindolol]

where KDis the dissociation constant of l25I-iodopindolol, and the [125I-iodopindolol] is the
molar concentration o f the radioligand.
The following equation was used to calculate the F values for determining a onesite versus a two-site model for competition by ICI-118551:

SS, - SS2

dFx - dF2

F(dFrdF^j

^
W2

SS, and SS2 are residual sums of squares with corresponding degrees of freedom
dFt and dF2 for one- and two-site models, respectively. This value was calculated by
GraphPAD Prism (San Diego, CA).

In membrane preparations. B-ARs are presented as finole/mg protein. Total B-ARs
were obtained by subtracting binding in the presence of propranolol from total binding. B2ARs were calculated as the mean of: a) the difference between binding displaced by ICI118551 and total binding and b) the difference between binding displaced by propranolol
and binding displaced by CGP-20712A. Bt-ARs were calculated as the mean of: a) the
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difference between binding displaced by CGP-20712A and total binding and b) the
difference between binding displaced by propranolol and binding displaced by ICI-118551.
Each value was doubled because the radioligand concentration 35 pM binds 50% of total
B-AR. The number of total B-ARs and each receptor subtype in myometrium,
disaggregated cells, and 24 hrs cultured cells were compared by ANOVA. Dunnet’s test
was used for further multiple comparisons.

cAMP Production and Radioimmunoassay

In intact cells
cAMP production was measured using the method of Halper and others (1984) in
the absence or presence of B2-adrenoceptor agonists (terbutaline or ritodrine), (-)isoproterenol (1 pM), G protein stimulant A1F/ (10 mM NaF/10 pM A1C13), direct
adenylyl cyclase activator forskolin (24 pM), or nonadrenergic adenylyl cyclase activator
prostaglandin Et (PGE^ 10 pM). Additionally, the assay contained 106 leukocytes or
5x10s myometrial cells and 20 or 200 pM of phosphodiesterase inhibitor 3-isobutyl-1methylxanthine (IBMX) in a final volume of 1 mL. Following incubation at 37°C for 15
min, the reaction was terminated by boiling for 5 min. The mixture was centrifuged at
2500xg for 15 min at 4°C and the supernatant frozen at -80°C for later cAMP analysis.

In membrane preparations
AC was measured using a modification of the technique of Litime and others
(1989). Cell membranes (20 pg protein) from each group were incubated without (basal)
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or with isoproterenol (1 pM), or forskolin (24 pM) in glass tubes containing final
concentrations o f 50mM Tris-HCl, 5 mM M gS04, 0.05 mM ATP, an ATP-regenerating
system (5 mM creatine phosphate and 120U/ml creatine phosphokinase), 0.1% bovine
serum albumin (fraction V) and 0.2 mM IBMX at 37°C for 10 min. The reaction was
terminated by boiling for 5 min. The mixture was centrifuged at 2500xg for 30 min at 4°C
and the supernatant frozen at -80 °C for later cAMP analysis. Forskolin-stimulated cAMP
production was considered as an internal control for adenylyl cyclase activity.
The supernatant was assayed using a cAMP radioimmunoassay (RIA) kit. The
standard cAMP solution was diluted to seven concentrations from 50 pmole/ml to 0.5
pmole/ml. Including a total counts (cAMP [I25I]-tracer), a blank (cAMP [125I]-tracer with
two volumes of assay buffer), and a zero standard (cAMP [125I]-tracer and equal volumes
of cAMP carrier serum and assay buffer), these 10 standard tubes were assayed in
duplicate. For each standard or sample tube, except the total counts tubes, 50 pi was
pipetted into wells of a 96-well Multiscreen GF/C glass fiber plate. Diluted tracer (50 pi)
solution, containing equal amounts of cAMP [l25I]-tracer and cAMP carrier serum, was
added to each well. Diluted antiserum complex (50 pi) was added to each well and the
plate was covered and incubated at 2-8 °C overnight (16-18 hours). The total counts tubes
were set aside. Following incubation cAMP precipitator (125 pi) was added to each well.
After mixing, the plate was vacuum filtered. The total counts tubes and the GF/C filters
were counted in a Beckman gamma counter for two minutes per sample. The average of
two blank counts was subtracted from the average standard or sample counts as an
average net count. The net counts for each standard or sample were expressed as a

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

32
percentage of the average net count for the zero standard. This is called "normalized"
percent bound or %B/B0.
o
/ qB/b

0

_ Average Net Counts o f Standards, Samples x jqq
Average Net Counts o f Zero Standard

The %B/B0 for each standard was plotted against the corresponding Log scale
concentration of cAMP in pmole/ml. Each experimental sample was interpolated from the
standard curve.
The value for cAMP production was corrected to give pmole per 106 cells per 15
min for intact cells. The background cAMP level of the membrane preparation incubation
buffer was subtracted. A linear relationship between membrane protein and cAMP
production was obtained. cAMP production in membrane preparations is presented as
pmole per mg protein per 10 min.

Long-term 200 nM Terbutaline Treatment for Cultured Leukocytes and Myometrial Cells
Myometrial cells or leukocytes were exposed to 200 nM terbutaline for 0
(control), 1 or 3 days before the cells were used to assess B-ARs and cAMP production
according to the design in Fig. 4.

Statistics
Values are summarized as mean ± standard error. The KDand B , ^ were analyzed
by paired or unpaired t-test depending on experimental design. A three-way analysis of
variance was used on cAMP data to assess leukocyte group (fresh or incubated), cAMP
stimulation (basal, isoproterenol, A1F<‘, forskolin, or PGE,) and the interaction. Analysis
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Cell Culture Time Course
0 Day
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1 Day
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I
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J _____________ I
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Figure 4. Experimental design for long-term 200 nM terbutaline treatment.

of variance was also used in comparing cAMP stimulation in myometrial cells and
leukocytes, and in total B-AR, receptor subtypes, and cAMP production in fresh
myometrium, disaggregated cells or 24 hrs cultured cells. Because of heterogeneous
variances across the experimental conditions in Fig. 14, 21, 22, the student's paired t-test
or unpaired t-test was used for comparison of means. Statistical analysis was performed
using GraphPAD Prism and MINITAB (Addison-Wesley, Reading, PA) software. P
values of less than 0.05 were considered significant.
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CHAPTER 3
RESULTS

Cellular Isolation Conditions in Leukocytes and Myometrium

Effect of Ca2*. Mg2* on Leukocyte cAMP Production
When mononuclear leukocytes were washed in Ca2*, Mg^-free DPBS buffer,
isoproterenol-coupled cAMP production was decreased by 74% from 14.9 ± 1.3 to 3.9 ±
0.6 (Fig. 5). There was no apparent shift in the EC50 for isoproterenol between Ca2*, Mg2*
containing buffer (16nM; pEC^ = 7.8 ± 0.1, n=5) and Ca2+, Mg2* free buffer (20nM;
pECso = 7.7 ± 0.1, n=4).

c

-♦•With Ca2+, Mg2+
O Without Ca2+, Mg2+

o

•I

o
3
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-4

-3

Log[lsoproterenol], M
Figure 5. Basal (B) and isoproterenol-stimulated cAMP production in freshly
isolated leukocytes isolated in DPBS with (n=5) or without (n=4) Ca2*, Mg2*.
Error bars less than the symbol width are not shown.
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Freshly Isolated Compared to Cultured Leukocytes and Myometrium
The binding affinity (KD) and total receptor number ( B ^ for I2SI-iodopindolol at
B-ARs were similar in fresh leukocytes and leukocytes cultured for three days (Table 1,
paired t-test, n=4).
In both fresh and cultured leukocytes (Fig. 6 ) cAMP was significantly increased by
isoproterenol (1 pM), forskolin (24 pM), and PGEt (10 pM), but not by A1F4*(10 mM
NaF /10 pM A1C13). After culture for three days in medium containing 10% FCS, there
was an 85% decrease in basal, isoproterenol, A1F4', and forskolin cAMP production, and a
70% decrease in PGEj-stimulated cAMP production.

Table 1. l2SI-IODOPINDOLOL Kd AND
AND AFTER CULTURE

IN LEUKOCYTES BEFORE

Before Culture

After Culture

Kd
(picoMolar)

33.1 ± 5.2

34.6 ±8.9

BmaX
(Sites per Cell)

525 ± 79

796 ±217
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Figure 6 . Basal and isoproterenol-, A1F4'-, forskolin-, PGEj-stimulated
cAMP production were compared between freshly isolated (n=9) and three
days cultured (n=9) leukocytes.
represents a significant difference from
group basal.

Total B- and B2-AR number in myometrium membranes decreased significantly
during the disaggregation and first 24 hours in culture (Fig. 7; Table 2). The B,-AR density
and percentage did not change significantly in cells cultured for 24 hours. Nonspecific
binding was 61.8 ± 1.7% of total binding at 35 pM 125I-iodopindoIol.
Forskolin-stimulated cAMP production was significantly increased in fresh
myometrium but not in disaggregated myometrium or myometrial cells cultured for 24
hours (Fig. 8 ). There was no difference between basal and isoproterenol-stimulated cAMP
levels in either fresh, disaggregated, or 24 hour cultured myometrium.
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Figure 7. The density of total B-ARs, B2-ARs, and B,-ARs in membranes
prepared from fresh human myometrium, disaggregated cells, and cells
cultured for 24 hrs. “+” represents a significant difference from fresh
myometrium by ANOVA and Dunnet’s multiple comparison, n= 8 .

Table 2. TOTAL, Br , AND B2-AR DENSITY IN FRESH HUMAN MYOMETRIUM,
DISAGGREGATED MYOMETRIUM, AND 24 HOURS CULTURED
MYOMETRIUM (Data for Fig. 7).
Unit:
(finol/mg protein)

Fresh Myometrium

Disaggregated
Myometrium

Cultured
Myometrium

Total B-AR

4.76 ± 0.22

3.48 ± 0.19+

2.67 ± 0.30+

b2-a r

3.93 ± 0.29

2.89±0.16+

2.10 ± 0.24+

Br AR

0.83 ±0.18

0.58 ±0.10

0.58 ±0.14

“+” represents a significant difference from the fresh myometrium.
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Figure 8 . Basal, isoproterenol- and forskolin-stimulated cAMP production in
membranes prepared from fresh human myometrium, disaggregated cells, and
cells cultured for 24 hrs.
represents a significant differences from group
basal. “+” represents a significant differences from fresh myometrium by
ANOVA and Dunnet’s multiple comparison, n=8 .

Human Mvometrial Smooth Muscle Culture and Identification

Mvometrial Cell Culture
Cultured myometrial cells were confluent (Fig. 9) after one to two weeks of
incubation depending on the number of cells placed in the flask, and were used within
seven passages.

Mvometrial Smooth Muscle Cell Identification
The spindle-shaped fluorescence pattern following treatment with phalloidin
CPITC was characteristic o f myometrial smooth muscle (Fig. 10). Myofibroblasts have a
basket-weave fluorescent pattern following phalloidin treatment (Casey and others 1984).
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Blood and endothelial cells were not seen.

Figure 9. Confluent myometrial cells grown in DMEM-F12 medium containing
10% FCS. Magnification = 128 fold.

Figure 10. Cultured myometrial cells stained with fluorescent phalloidin, a
fluorescent toxin specific for filamentous actin. The spindle-shaped fluorescent
pattern is characteristic of myometrial smooth muscle. Magnification = 200
fold.
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Comparison o f fl-Adrenoceptors between Cultured Leukocytes and Mvometial Cells
Total binding of l25I-iodopindolol to B-ARs was resolved in both leukocytes (Fig.
11) and myometrial cells (Fig. 12) by curve-fitting using a model of a specific and
nonspecific binding.

6OOO1
Total Binding

45003000-

Nonspecific Binding

1500

Specific Binding

0

100

200

300

400

500

600

[125l-Pindoloq, pM
Figure 11. A representative saturation binding curve for l25I-iodopindolol in
human mononuclear leukocytes. Total binding was mathematically separated into
specific and nonspecific binding.

125I-iodopindolol binding was saturable and displayed properties of a single specific

binding site in both leukocytes and myometrial cells. The binding affinity (KD) and
receptor density (B,^*) were obtained from specific binding to B-ARs (Table 3, n=7). KD
values were similar for leukocytes and myometrial cells (p>0.6). Receptor density ( B ,^ )
was 43% higher for myometrial cells compared to leukocytes (p=0.06). Nonspecific
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Figure 12. A representative saturation binding curve for 125I-iodopindolol in
cultured human myometrial cells. Total binding was mathematically separated
into specific and nonspecific binding.

binding was approximately 25% and 49% of total binding in leukocytes and myometrial
cells respectively at KD concentration.

Table 3. BINDING CHARACTERISTICS FOR 125I-IODOPINDOLOL IN
MONONUCLEAR LEUKOCYTES AND MYOMETRIAL CELLS
Kd
picoMolar

®MAX
Sites per Cell

Leukocytes

34.3 ± 13.1

673 ± 64

Myometrial Cells

27.1 ± 4.7

962 ± 121
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Comparison of cAMP Production between Cultured Leukocytes and Mvometrial Cells
The difference between basal and maximal isoproterenol-stimulated cAMP
production was 66 % in fresh leukocytes, 61% in three day cultured leukocytes, and 15%
in myometrial cells (Fig. 13). There were no differences between EC^ values for
isoproterenol in freshly isolated leukocytes (17.5nM; 95% confidence intervals o f pECjo =
8.04 to 7.47) and myometrial cells (39nM; 95% confidence intervals of pEC*, = 9.17 to
5.65), or cultured leukocytes (164 nM; 95% confidence intervals of pEC^ = 7.39 to 6.18)
and myometrial cells, but cultured leukocytes had a significantly higher ECso than freshly
isolated leukocytes.

e 120&
0
3

1

Q_
Q_
5
<u
0
O)

1

80

-•-F re sh Leukocytes
O C u ltu re d Leukocytes
-■-Myometrial Cells

40H

o
a
o
a.

B

-10

-9

-8

-7

-6

-5

-4

-3

LogPsoproterenol], M
Figure 13. Isoproterenol-stimulated cAMP production in freshly isolated
leukocytes (n=9), three days cultured leukocytes (n=9), and cultured
myometrial cells (n= 12).
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cAMP production was also compared following stimulation using B-AR agonist
isoproterenol, G protein activator A1F4', AC stimulator forskolin and PGE, in freshly
isolated leukocytes, leukocytes cultured for three days, and untreated cultured myometrial
cells (as shown in Fig. 14; Table 4). Myometrial cells had significantly higher basal cAMP
production compared to freshly isolated leukocytes (16.5 ± 3.0 compared with 5.6 ± 0.8
pmol/106 cells/15 min; p<0.01). Myometrial cell forskolin- and PGE^stimulated cAMP
production (381 ± 72 and 430 ± 87 pmol/106 cells/15 min) was > 10-fold higher than that
in freshly isolated leukocytes (23 ± 6 and 41 ± 3 pmol/106 cells/15 min), but was
depressed in leukocytes maintained in culture for three days (4.1 ± 0.9 and 12.6 ±1.6
pmol/106 cells/15 min). When using data in Fig. 13, basal cAMP production expressed as a
percentage of isoproterenol maximum was significantly greater (p<0 .000 1 ) for myometrial
cells (64 ± 7%) than for fresh (24 ± 3%) or cultured leukocytes or (28 ± 5%). For each
tissue, cAMP production increased significantly following stimulation with isoproterenol,
forskolin or PGELStimulation of G-proteins by A1F4*increased cAMP production in
leukocytes by 16% (p=0.26), but decreased cAMP production in myometrial cells by 27%
(p=0 . 10 ).

Comparison of B-Adrenoceptor Subtvpes between Cultured Leukocytes and Mvometrial
Cells
B2-selective antagonist ICI-118551 displaced t25I-iodopindolol binding in cultured
leukocytes (Fig. 15) with two distinctive dissociation constants for B, (lo g K ^ -6.7 ±
0.21) and B2 (lo g K ^ -10.0 ± 0.65) adrenoceptors. The ratio of Bi : B2 was 3 : 1 in
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Figure 14. cAMP production stimulated by isoproterenol, A1F4\ forskolin,
and PGE, was compared in freshly isolated, three days cultured leukocytes,
and cultured myometrial cells.
represents a significant difference from
group basal (n=9) by paired t-test.

Table 4. BASAL, ISOPROTERENOL, A1F4\ FORSKOLIN, AND PGE, STIMULATED
cAMP PRODUCTION IN FRESH LEUKOCYTES, THREE DAYS CULTURED
LEUKOCYTES, AND CULTURED MYOMETRIAL CELLS (Data for Fig. 14)
Unit: pmol/106
cells/15 min

Fresh Leukocytes

Cultured
Leukocytes

Cultured
Myometrium

Basal

5.59 ±0.79

0.88 ±0.16

16.5 ±3.0

Isoproterenol

23.6 ± 2 .7 *

3.59 ±0.55 *

26.7 ± 4 . 8 *

a if 4-

6.47 ± 0.65

0.82 ± 0.11

12.0 ± 1.9

Forskolin

23.2 ± 6 . 2 *

4.10 ±0.88 *

381 ± 7 2 *

PGEX

41.4 ± 3 . 4 *

12.6 ± 1.6 *

430 ± 87 *

“*” represents a significant difference from group basal.
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Figure 15. Displacement of I23I-iodopindolol binding by ICI-118551 in
cultured human mononuclear leukocytes (n=6 ).

leukocytes. A two site model fit significantly better than a one-site model (FU6 = 11.49, P
< 0 . 01 ).

ICI-118551 displaced l25I-iodopindolol from myometrial cells (Fig. 16)
characteristics of a single 3, site with a logK*, of -6.4 ± 0.07. A two site binding model
did not fit the data significantly better than a one-site model (F^10 = 1.627, p = 0.244).
There was no significant difference between the IC*, values for Bj-ARs of leukocytes and
myometrial cells.
To determine if displacement binding in whole cells provided an accurate estimate
o f B-AR subtypes, experiments were performed in fresh leukocytes, an established B2
model (Brodde and others 1981). In intact fresh leukocytes (Fig. 17), a two site model
fitted significantly better than a one site model (Fil5 =10.12, P< 0.01). Two distinctive
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constants were logKil = -5.7 ± 0.19 for Bt and logK^ = - 11.1 ± 0.98 for B2. The ratio of B,
: B2 was 4:1.
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Figure 16. Displacement of l25I-iodopindolol binding by ICI-118551 in
cultured human myometrial cells (n=4).
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Figure 17. Displacement o f 125I-iodopindolol binding by ICI-118551 in fresh
human mononuclear leukocytes (n=9).
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B-Adrenoceptor Agonists Potencies between Cultured Leukocytes and Mvometrial Cells
B-AR agonists differ in both EC*, and maximum effect in fresh leukocytes (Fig.
18). Isoproterenol was the most potent (EC^ =15.5 nM) and produced maximal cAMP
production at concentrations above 1 pM. Terbutaline was less potent (EC^ = 373 nM)
than isoproterenol but produced similar cAMP production at 10 pM. Ritodrine was
considerably less potent and produced a significant increase in cAMP production only at
the highest concentration tested (1 mM).
In cultured myometrial cells, isoproterenol differed from basal only when larger
numbers of patients are included (compare Fig. 14 & Fig. 19). Terbutaline and ritodrine
produced no change in cAMP production in cultured myometrial cells (Fig. 19).

Effect of Long-term 200 nM Terbutaline Exposure

B-Adrenoceptors
B-Adrenoceptor number decreased in both leukocytes and myometrial cells after
exposure to 200 nM terbutaline. Leukocyte B-AR number decreased 20% when incubated
for one day and was significantly reduced by 27% when incubated for three days (Fig. 20).
Myometrial B-AR number significantly decreased by 42% when incubated for one day and
by 28% after three days. There were no changes noted in the dissociation constant (KD) of
ICI-118551 in either leukocytes or myometrial cells during the three days exposure to 200
nM terbutaline.
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Figure 18. cAMP production in response to B-agonists isoproterenol,
terbutaline, and ritodrine in freshly isolated leukocytes (n=5).

C 25i

♦ Iso p ro teren o l
-O T e rb u ta lin e

12 20T3

♦

R itodrine

1510-

B

-10

-9

-8

-7

-6

-5

-4

-3

Log[Drug], M
Figure 19. cAMP production in response to B-agonists isoproterenol,
terbutaline, and ritodrine in cultured myometrial cells (n=4).
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Figure 20. Total B-adrenoceptor number (Bmax) changes after 200nM
terbutaline treatment for one or three days in cultured leukocytes (n=4) and
myometrial cells (n=4).
represents a significant difference from control by
paired t-test.

cAMP Production
Basal, isoproterenol-, A1F4*-, forskolin-, and PGEr stimulated cAMP production
were significantly higher in myometrial cells than in cultured leukocytes. Leukocytes
exhibit a significant decrease in isoproterenol-coupled cAMP production following one
day or three days exposure to terbutaline (Fig. 21; Table 5). Myometrial cells also have a
significant decrease in isoproterenol-coupled cAMP production (compared by paired ttest) following three days of terbutaline treatment (Fig. 22; Table 6 ). There was no
significant change in A1F4', forskolin, or PGE, stimulated cAMP production following one
or three days exposure to 200 nM terbutaline. The percentage of forskolin- to PGEr
stimulated cAMP production in the control group is 21% in leukocytes and 88 % in
myometrial cells. The ratio of isoproterenol- to forskolin-stimulated cAMP production in
the control group is 1.36 in leukocytes and 0.036 in myometrial cells.
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Figure 21. cAMP production under basal condition and after A1F4*, forskolin,
and PGE, stimulation was not changed following one or three days exposure
to 200nM terbutaline, except that isoproterenol-coupled cAMP production
significantly decreased after one and three days treatment in human
mononuclear leukocytes (n=3).
represents a significant difference from
control by ANOVA and Dunnet’s multiple comparison.

Table 5. cAMP PRODUCTION BEFORE AND AFTER STIMULATION WITH
ISOPROTERENOL, A1F4\ FORSKOLIN, AND PGE, IN LEUKOCYTES EXPOSED
TO 200 nM TERBUTALINE FOR 0 (CONTROL), 1, OR 3 DAYS (Data for Fig. 21)
Unit: pmol/106
cells/15 min

Control

1 Day

3 Day

Basal

0.71±0.15

0.63±0.12

0.68±0.18

Isoproterenol

5.00±1.22

1.56±0.85*

1.05±0.19*+

a if 4-

1.01±0.34

0.75±0.15

0.96±0.14

Forskolin

3.68±0.2r

3.44±0.20+

3.00±0.27+

PGE,
17.82±1.75*
16.70±2.52+
14.93±2.10+
“+” represents a significant difference from the basal o f that same day.
represents a significant difference from control stimulation group.
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Figure 22. cAMP production under basal conditions and after A1F4‘,
forskolin, and PGE, stimulation was not changed following one or three day
exposure to 200nM terbutaline, except that isoproterenol-coupled cAMP
production significantly decreased after three days treatment in cultured
human myometrial cells (n=4).
represents a significant difference from
control by pair t-test.

Table 6 . cAMP PRODUCTION BEFORE AND AFTER STIMULATION WITH
ISOPROTERENOL, A1F/, FORSKOLIN, AND PGE, IN MYOMETRIAL CELLS
EXPOSED TO 200 nM TERBUTALINE FOR 0 (CONTROL), 1, OR 3 DAYS (Data for
Fig. 22)
Unit: pmol/106
cells/15 min

Control

1 Day

3 Day

Basal

9.22±3.34

9.65±3.26

9.50±3.11

Isoproterenol

12.51±4.05+

9.72±2.93

10.32±3.76*

aif 4-

12.11±1.17

11.71±0.31

9.14±2.54

Forskolin

348.4±59.8

409.3±74.5

405.4±5.8+

PGE,
629±229
394.2±93.0
480.9±60.9
“+” represents a significant difference from the basal of that same day.
represents a significant difference from control stimulation group.
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O-Adrenoceptor Subtypes in Isoproterenol-Induced Mvometrial Relaxation
Potassium chloride (35 mM) produces a phasic contraction o f human myometrial
strips followed by a less intense tonic contraction. When this tonic contraction was
designated as 100 % after ten minutes of exposure and compared to resting tension (0 %),
only an 8 % further relaxation occurred over the following 45 minutes (Fig. 23). In the
presence of isoproterenol a concentration-dependent decrease in contraction occurred to
26 ± 5% at 1 pM.
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Figure 23. Isoproterenol relaxation of myometrium contracted with 35 mM
KCI (n=5).

Isoproterenol produced a maximum relaxation of 46.5% (from 4.1 ± 1.3% at 10'9
M to 50.6 ± 3.6% at 10'5 M) with a pEC^ of 7.39 ± 0.05 (Fig. 24). In the presence of 0tantagonist CGP-20712A, isoproterenol-induced myometrial relaxation was similar to
control with a maximum relaxation of 41.6% (from 1.2 ± 0.6% at 10'9M to 42.8 ± 5.6%
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at 10*s M) and pECMo f 7.31 ± 0.12. In the presence of B2-antagonist ICI-118551,
isoproterenol-induced myometrial relaxation was shifted to the right and depressed, with a
maximum relaxation of 23.5% (1.5 ± 0.6% at 10'9M to 25.0 ± 5.6% at 10'5 M) and a
pEC^ o f 5.97 ± 0.10 (n=8 ). In control and CGP-20712A treated tissues, isoproterenol
produced contraction at concentrations above 10 pM. When determined from
concentration-effect curve shifts at ECIS, the pKBo f ICI-118551 is9.11 ±0.21.
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Figure 24. Isoproterenol-induced myometrial relaxation in the absence
(control) and presence of ICI-118551 or CGP-20712A (n= 8 ).
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CHAPTER 4
DISCUSSION

The current experiments were designed to compare leukocyte and cultured
myometrial cells in terms of B-adrenoceptors, cAMP production and response to
terbutaline exposure. The goal of these experiments was to understand more about the
relationship between pregnant human myometrium, fresh and cultured leukocytes, and
cultured myometrial cells.

Establishment o f Experimental Conditions

Leukocyte Cell Culture
In the present study, leukocytes from male volunteers were used to minimize the
impact o f patient hormonal status on B-ARs and cAMP coupling. Even though menstrual
changes produce no effect on B-ARs in women (Santala and others 1990), menstrual
effects on cAMP production have not been established. Although uterine samples obtained
during Cesarean delivery may vary in hormonal status, by the time these smooth muscle
cells are grown in culture for 10 to 14 weeks and used experimentally their hormonal
status should be dictated by the growth medium.
Leukocytes were isolated in the presence o f calcium and magnesium since
omission of these ions at any time during the isolation procedure resulted in a dramatic
decrease in cAMP production. Phosphodiesterase inhibitor IBMX was added at
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concentrations that maximized stimulated cAMP production with minimal effects on basal
cAMP production.

Mvometrial Cell Culture
Conditions for cultured human myometrial smooth muscle cells were similar to
those reported by other investigators (Casey and others 1984). FCS 10%, different
collagenases in a variety of cell culture media, including MEM, DMEM, or DMEM/Ham's
FI 2 , and with varying concentrations o f antibiotics have been used successfully during
tissue dispersion or culture (Zhu and others 1992; Erulkar and others 1993; Komyei and
others 1993). Human myometrial smooth muscle cells have a doubling time of 41.6 hours
(Rossi and others 1992), and can be cultured for at least 16 passages or for one year
without loss of smooth muscle characteristics (Casey and others 1984).
Cultured human myometrial smooth muscle cells were identified by Casey and
others (1984) using phallacidin, a filamentous actin-binding fluorescent compound derived
from Amanita phalloides. This is similar to the phalloidin coumarin phenyl isothiocyanate
(phalloidin-CPITC) used in current study for morphologic evaluation o f myometrial
smooth muscle cells. Casey and others (1984) found long, parallel arrays of filamentous
actin to be characteristic o f smooth muscle cells in situ, whereas a net-like pattern of
staining is characteristic of fibroblasts. The intensity of fluorescence observed in smooth
muscle cells was much greater than in myometrial fibroblasts, suggesting that filamentous
actin was more abundant in smooth muscle cells. Other groups have instead used
immunofluorescence microscopy with antibodies against smooth muscle specific a-actin,
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desmin, and/or vimentin (Rossi and others 1992; Erulkar and others 1993; Korayei and
others 1993). With these methods, they determined that more than 90% of cultured cells
were smooth muscle cells. Fluorescence microscopy of cultured myometrium in the
current study suggests an almost pure population of myometrial cells (Fig. 9).
Cultured myometrial cells have been shown to reflect myometrium muscle in
biochemical and electrophysiological studies. Myometrial muscle strips and cultured
myometrial cells have similar myosin content, myosin light chain kinase activity, and
increase in intracellular calcium concentration following KCI stimulation (Richardson and
others 1987). Platelet-activating factor receptors with properties similar to those of human
myometrium are found in cultured human myometrium and produce an increase in
intracellular Ca2+ concentration and myosin light chain phosphorylation in the presence of
platelet-activating factors (Zhu and others 1992). Potassium channels exist in both
cultured human myometrium (Erulkar and others 1993) and myometrium muscle strips
(Wallner and others 1995). Cultured myometrium contains human chorionic gonadotropin
hCG/LH receptors, which increase the growth rate (Komyei and others 1993) and are also
found in myometrium (Eta and others 1994). Endothelin receptor and myosin light chain
phosphorylation have been demonstrated in tissue and cultured cells (Word and others
1990, 1991). The present study measured B-AR density, receptor coupled cAMP
production and down-regulation following prolonged terbutaline exposure in intact
cultured human myometrial cells. These experiments further evaluate the culture model in
terms o f B-ARs.
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Saturation Binding Conditions
Saturation binding studies were designed to measure the total B-ARs in intact cells.
Radioligand t25I-iodopindolol was chosen because of its high affinity for the B-AR and low
nonspecific binding. Its lipophilicity permits the ligand to pass through the cell membrane
and bind to both membrane and internalized B-ARs. Moreover, 125I-iodopindolol binding in
cell membranes is inhibited by isoproterenol and retains stereoselectivity for inhibition by
(-)- and (+)-propranolol (Szefler and others 1987).
Isolated intact cells were chosen because of the advantage of maintaining a
structural and metabolic state close to that which exists in vivo (Williams and Lefkowitz
1978), and estimating total B-ARs without a loss of receptors during membrane
preparation (Santala and others 1989). Studies using intact cells can be performed using
less tissue than studies requiring isolation o f membrane protein, but intact cells are subject
to clumping, and can also take up ligand into intracellular compartments more readily than
membrane preparations (Marinetti and others 1983).
Although the incubation temperature was chosen according to physiological body
temperature, incubation temperature does not affect saturation binding of I25I-iodopindolol
in intact human lymphocytes (Waldo and others 1983; Thede-Reynolds and others 1986).

Displacement Binding Study
ICI-118551, a more selective B2-AR antagonist than butoxamine or atenolol in
displacing 12sI-iodopindolol, was chosen because its dissociation constants for B2- and B,ARs are distinctly different. The dissociation constants for B2- and Br ARs are 0.1 nM and
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0.2 pM respectively in intact cultured leukocytes. These values are similar to those
reported by Molenaar and Summers (1987) and Molenaar and others (1988) in both
guinea pig atrium and canine coronary artery (KDvalues around I nM for B2-ARs and 0.13
pM for B,-ARs). The KDvalues for Br AR antagonist CGP-20712A are 1 nM for B,-ARs
and 10 pM for B2-ARs (Molenaar and Summers 1987; Molenaar and others 1988). These
data suggest both compounds are highly selective and might be useful in differentiation of
B-AR subtypes.
Using displacement binding in intact fresh leukocytes showed 80% Br ARs.
%

Brodde and others (1981) used membrane preparations of human lymphocyte and found
100% B2-AR subtype. This difference may be due to the inability of ICI-118,551 to
penetrate through the intact cell membrane and displace iodopindolol binding. Therefore,
membrane preparations provide a better estimation of B-AR subtypes than intact cells. The
evaluation o f Br AR predominant in intact cultured leukocytes and myometrial cells
appears to be artificial and displacement binding in membrane preparations should be
considered.
Displacement binding in the membrane preparation of myometrium from tissue,
disaggregated cells and culture cells measured the total B-AR, B-AR subtypes and
presented results in the same units (fmol/1 0 min/mg protein).

Comparison of Cultured Leukocytes and Mvometrial Cells

B-Adrenoceptors
The leukocyte B-AR binding affinity (KD) for 125I-iodopindolol of 34.3 ±13.1 pM
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(Table 2) is within the range reported by other studies (Marsh and Smith 1985; ThedeReynolds and others 1986; Kowalski and others 1990; Landmann, 1992; Nwosu and Rice
1995). In the current study, the B-adrenoceptor

of 673 ± 64 sites per cell is similar to

that reported by O'Hara and Brodde (1984), Thede-Reynolds and others (1986), and
Nwosu and Rice (1995), but relatively lower than the range o f 1000-3000 sites per cell
reported by Landmann (1992). The B-AR density for human leukocyte subpopulation
estimated by antagonist radioligand iodocyanopindolol can vary from 3746 sites per B cell
to 642 sites per T cell (Landmann 1992). The presence o f leukocyte subpopulations
containing different B-AR density can explain interpatient variation in B ^ ^ and cAMP
production. Landmann (1992) also found that isoproterenol infusion or short periods of
exercise lead to an increased number of mononuclear B-ARs having a slightly reduced
proportion with high agonist affinity. This raises the issue of whether leukocytes can be an
precise index o f myometrium, a tissue containing a homogeneous receptor population at
term (Breuiller and others 1987).
Myometrial ,25I-iodopindolol binding affinity (KD; 27.1 dh 4.7 pM) was similar to
that reported by Michel and others (1989) (40.0 ± 4.2 pM) in a human myometrial
membrane preparation, and in intact leukocytes (Table 2). Our total B-AR number in
myometrial membranes (4.76 ± 0.22 fmol/mg protein at Fig. 7) is similar to that in the
human myometrium at term (5 fmol/mg protein) reported by Breuiller and others (1987).
Our B-AR number is lower than that reported by Michel and others (1989); (16.4 fmol/mg
protein) this may be due to differences in gestational age or sample location which were
not described in their paper.
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cAMP Production
Myometrial cells have higher basal cAMP production than either freshly isolated or
cultured leukocytes, and can be significantly stimulated by isoproterenol at 1 pM
concentration (Fig. 13, 14). The percentage increase of isoproterenol-stimulated cAMP
production is lower (15%) than in leukocytes (60%). In myometrial membranes from fresh
tissue, disaggregated tissue, and cells cultured for 24 hours (Fig. 8 ), isoproterenolstimulated cAMP production is not significantly different from basal. Litime and others
(1989), Grammatopoulos and others (1996), and Breuiller and others (1991) also reported
disappearance of B-adrenergic response in human myometrial adenylyl cyclase in vivo at
the end o f pregnancy. Reasons for this phenomenon are poorly understood, but may
include a higher basal level of cAMP production. Litime and others (1989) found a
decrease in the number of B-ARs in the last weeks of pregnancy, with an increase in basal
cAMP production, a loss of B-AR mediated cAMP production and reduced G-protein
coupling to adenylyl cyclase without a change in direct adenylyl cyclase stimulation. They
implicated modifications in the coupling mechanisms between receptors and the catalytic
component of adenylyl cyclase. Some researchers have suggested that involvement o f G
protein might be a further investigative direction in explaining this phenomenon. EuropeFinner and others (1993) used antibodies against Gia„ Gia^ Gia3, Gqa, and Gsa, to
compare changes in G proteins between pregnant and nonpregnant human myometrial
tissues and reported that increased Gsa levels play a crucial role in maintaining uterine
relaxation by favoring cAMP formation during pregnancy. Down-regulation of Gsa
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occurs in human myometrium at term and in preterm labor (Europe-Finner and others
1994).
The present data comparing the Gs protein stimulation between cultured
leukocytes and myometrial cells failed to provide any significant evidence. Two
explanations are considered for the inability of AJF4*to significantly affect cAMP
production in either leukocytes or myometrium. A1F4*may not pass through the intact cell
membrane and so fail to stimulate the G protein coupled cAMP level for either leukocytes
or myometrial cells. Second, A1F4*may partially enter the cells, and activate both Gs and
Gi proteins (Coggeshall and Altman 1989), producing an insignificant decrease in
myometrial cells, and an insignificant increase in leukocytes (Fig. 14). This explanation
would imply that the balance between stimulatory Gs protein and inhibitory Gi protein are
different in leukocytes and myometrial cells. The Gi protein may predominate in
myometrial cells while Gs predominates in leukocytes.
B-AR agonist isoproterenol has a higher potency in leukocytes than the B2-AR
agonists terbutaline and ritodrine (Fig. 18). These results indicate that isolated leukocytes
are a potential model for comparing the cAMP coupling potencies of B-AR agonists. In
contrast, isoproterenol, terbutaline and ritodrine have no effect on cultured myometrial
cells (Fig. 19). The 1 pM isoproterenol stimulated cAMP production was only significant
when large numbers of tissues were studied (Fig. 14, n=9). This difference between
leukocytes and myometrial cells implies a different activity of B-AR coupling to adenylyl
cyclase.
The basal cAMP level in leukocytes and myometrium may be regulated differently.
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In leukocytes, both basal cAMP level and forskolin stimulated adenylyl cyclase activity
decrease after three days o f culture (Fig. 6 ). In myometrium, forskolin stimulation of
myometrial adenylyl cyclase activity decreases during the time from tissue isolation to 24
hours culture (from 167.6 to 46.8 pmol/10 min/mg protein) (Fig. 8 ). However, basal
cAMP level did not change during myometrial cell isolation. Although the factors
regulating myometrial basal cAMP level at the end of pregnancy are unknown, the basal
cAMP level in the present study is not affected by B-AR number or total adenylyl cyclase
activity measured by forskolin.

Long-term Terbutaline Exposure
B-AR density and isoproterenol-stimulated cAMP production were decreased in
both leukocytes and myometrium after continuous treatment with B2-AR agonist
hexoprenaline (Michel and others 1989) or terbutaline (Berg and others 1984, 1985). The
routes of administration and dosages of terbutaline used by Berg and others (1984) make
it difficult to compare plasma concentration with the current study. Terbutaline plasma
concentrations which inhibit uterine contraction range from 57 to 140 nM (Lyrenas and
others 1986). The terbutaline concentration of 200 nM used in current study, should be
typical of concentrations achieved clinically and is sufficient to induce a decrease in B-AR
density (Fig. 20) and isoproterenol-stimulated cAMP production in both cultured
leukocytes (Fig. 21) and myometrial cells (Fig. 22).
Agonist-induced homologous desensitization is a complex process. It involves the
uncoupling o f the receptor from Gs protein through the phosphorylation by B-AR kinase
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(Benovic and others 1988), and receptor internalization and sequestration as well as later
degradation (down-regulation) o f the receptor (Benovic and others 1988). Although
agonist-induced down-regulation of B-ARs has been well documented (Stiles and others
1984; Hausdorff and others 1990; Dohlman 1991; Von Zastrow and Kobilka 1992),
investigations dealing with the agonist-induced changes in G proteins, AC, and the PGE 1
heterologous pathway are unreported. To elucidate which components are altered during
down-regulation, cAMP production stimulated by isoproterenol, G protein activator A1F4‘,
AC stimulator forskolin, and PGE, were measured following terbutaline-induced B-AR
down-regulation in leukocytes and cultured myometrial cells. Data in this study
demonstrate that the activity.of AC and the PGE! pathway has not changed during
terbutaline-induced B-AR down-regulation (Figs. 21, 22). This characterization of
desensitization to B-AR agonists is similar to the findings by Dayes and Lye (1990), and
Engelhardt and others (1997). Dayes and Lye (1990) found continuous exposure of ovine
myometrial strips to isoproterenol (10 pM) induces a state of desensitization that is
associated with a down-regulation of B-ARs but maintenance of postreceptor function.
Engelhardt and others (1997) found long-term use of B-AR agonist fenoterol causes a
decrease in B-AR but not in mRNA, Gs, Gi, or B-AR kinase activity.
The high PGE^stimulated AC activity in both leukocytes and myometrial cells
suggests that both cell types have reserve AC activity not used by B-ARs. The ratio o f
cAMP production following forskolin to that following PGE, is higher in myometrial cells
than in leukocytes suggesting that myometrial cell AC has a higher sensitivity to forskolin
than leukocytes, and that the AC isozyme in myometrial cells may be different from that in
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leukocytes. The ratio o f cAMP production following isoproterenol and forskolin is higher
in leukocytes than in myometrial cells. This result further supports that the efficacy o f
isoproterenol-stimulated cAMP production in leukocytes is higher than that in myometrial
cells.

Fresh Tissue Versus Cultured Cells

Myometrium Functional Studies
KC1 produces phasic contractions at low concentration, but tonic contraction at
higher concentration. Phillippe and Chien (1995) found KC1 at 10 to 30 mM can stimulate
phasic myometrial contraction by utilizing cytosolic calcium oscillation-like mechanisms.
These potassium-stimulated phasic contractions were suppressed in response to inhibition
of phospholipase C, stimulation of protein kinase C, inhibition o f calcium-induced calcium
release, and prevention of extracellular calcium influx. Qualitative inositol-phosphate
production studies confirmed activation of phospholipase C in response to 20 mM
potassium (Phillippe and Chien 1995). Rat myometrium cell shortening and tonic
contraction o f muscle strips occurred while depolarizing with 60 mM KC1 in 2 mM Ca2+
solution; no contractions occurred if nitrendipine or 4 mM of EGTA was added (Kyozuka
and others 1987). This result suggests that Ca2+ influx is necessary to maintain tonic
contraction following high K* depolarization (Fig. 1).
Although Bj-ARs are predominant and known to produce uterine relaxation, the
role o f cAMP coupling and B,-ARs in uterine relaxation has not been explored. In the
present study, the nonselective B-AR agonist isoproterenol was used to relax human
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myometrium. According to Arunlakshana and Shild (1959) analysis in detection of
heterogeneous receptor population, the assumption o f linearity and slope of unity between
logarithmic antagonist concentrations and log dose ratio can be used to estimate the
antagonist dissociation constant. Nonlinearity and a slope of less than unity may be
obtained for Schild regressions at dose ratios less than 10. Therefore, two competitive BAR antagonists, a Br AR antagonist (CGP-20712A, KD 10'9 M) and a B2-AR antagonist
(ICI-118551, Kd 10'9 M), were used at concentrations 100-fold higher than their
dissociation constants to differentiate the contribution o f each receptor subtype (Molenaar
and Summers 1987, Molenaar and others 1988). If 6,-ARs are mainly involved in uterine
relaxation, the isoproterenol-induced relaxation dose response curve in the presence of
CGP-20712A would exhibit a 100-fold parallel right shift from the control curve. If B,ARs are mainly involved in uterine relaxation, the isoproterenol-induced relaxation dose
response curve in the presence of ICI-118551 would exhibit a 100-fold parallel right shift
from the control curve. A shift in the isoproterenol concentration-relaxation curve
occurred in the presence of ICI-118551. Because isoproterenol contracted myometrium at
concentrations above 1 pM, the shift in the concentration-effect curve was estimated at
the ECIS. The pKB value o f 9.11 ± 0.21 for ICI-118551 is similar to that reported by Bilski
and others (1980) and O’Donnell and Wanstall (1980) for antagonism at Biadrenoceptors, and suggests that B2-ARs mediate uterine relaxation at the end o f
pregnancy. Breuiller and others (1991) reported that isoproterenol cannot relax KC1induced contractions in term human myometrium. Isoproterenol produced relaxation in all
but one patient (out of 9) in the current study.
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Isoproterenol did not produce maximum relaxation in the presence of ICI-118551.
The control and CGP-20712A pre-incubated groups demonstrated a contraction to
isoproterenol concentrations above 10 pM. The fact that contraction occurred at high
concentration o f isoproterenol alone, and in the presence of 8t- antagonist suggests at high
concentration o f isoproterenol may interact with other adrenergic receptor subtypes. The
a-AR is the most speculative one because of its link to uterine contraction and structural
similarity to B-ARs. Although this phenomenon has not been reported in human
myometrium, Kamata and others (1989) found that muscle contraction observed at high
concentrations of isoproterenol can be blocked by non-selective a-antagonist
phentolamine in rat aorta.

B-Adrenoceptors and cAMP
The fraction of B2-ARs in human myometrium membrane preparation (82.6%)
(Fig. 7) is similar to 85.1% reported by Michel and others (1989), but higher than the 63%
B2-AR reported by Breuiller and others (1987). This difference may be within the variation
of displacement binding studies.
Experiments with fresh myometrium were performed to examine B-AR, receptor
subtypes and B-AR coupled cAMP production in parallel. The high percentage (82.6%) of
B2-AR in the myometrium membrane displacement binding study indicates B2-ARs
predominate in fresh human myometrium and also mediate relaxation by isoproterenol.
cAMP production was not changed in the presence of isoproterenol (1 pM) which
produced maximum relaxation. This result confirms the loss o f B-AR coupling to cAMP
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production at the end of pregnancy as found by Litime and others (1989), Breuiller and
others (1991), and Grammatopoulos and others (1996). It also supports the hypothesis
that cAMP level does not reflect myometrial relaxation. The relationship between cAMP
and uterine relaxation was evaluated by Do Khac and others (1986), who found 13adrenoceptor mediated relaxation of the rat myometrium could not be ascribed solely to
cAMP because PGEj also stimulates cAMP production but causes contraction. Therefore,
they proposed that B-AR-linked relaxation includes a cAMP-dependent (sensitive to low
cAMP) and a cAMP-independent process. The cAMP-independent process is postulated
to produce a reduction in cytosolic Ca2+. cAMP would be the sole determinant for
forskolin-elicited relaxation provided cAMP reached a critical concentration essential to
mediate intracellular Ca2+ sequestration.
Isoproterenol was unable to stimulate adenylyl cyclase in fresh myometrial tissue
which contained higher adenylyl cyclase activity and more B-ARs than disaggregated or 24
hour cultured cells, suggesting that cAMP production is not determined by the number of
B-ARs in this tissue (Fig. 7, 8). The positive correlation in the number of B-ARs between
leukocytes and myometrium by Berg and others (1984), and Michel and others (1989)
does not necessarily mean that B-AR stimulation triggers the same amount of cAMP
production. Nwosu and Rice (1995) also found that cAMP production per receptor site is
constant at higher receptor densities, but appears to be increased when receptor densities
iire less than 400 sites per cell in human mononuclear leukocytes.
Since cAMP is not a good index for the relaxation of myometrium, and the
existence o f B-AR does not assure stimulation of cAMP production, using leukocyte B-AR
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coupling to cAMP production as an index for myometrium relaxation requires further
consideration. Additionally, leukocytes may be affected by patient’s emotion, hormonal
status, immunological situation (infection etc.) and other indirect effects. Avissar and
others (1997) found reduced G protein function and immunoreactivity in mononuclear
leukocytes from patients with depression. Connolly and others (1992) found that there is
an intrinsic impairment in the function o f B-ARs on peripheral mononuclear leukocytes
from subjects with high levels of nonspecific bronchial responsiveness. Szefler and others
(1991) observed that a significant change in B-AR density and leukocyte function occurs
at night in patients with nocturnal asthma. Zoukos and others (1994) found that increased
expression of high affinity IL-2 receptors and B-ARs on peripheral blood mononuclear
cells is associated with clinical and magnetic resonance imaging activity in multiple
sclerosis patients. Brodde and others (1986) compared B-ARs in human right atria to
circulating lymphocytes and obtained a direct relationship between human myocardium
and lymphocyte B-AR alterations. Taken together, using leukocytes as an index of
myometrium response may result in a poor estimation o f uterine relaxation following Bagonist therapy.
Fresh and cultured leukocytes have similar total B-AR number (Table 1), while
there is a loss of myometrium B-adrenoceptors during preparation and the first 24 hrs of
culture (Fig. 7). This variation in leukocyte B-ARs may be due to leukocytes redistributing
to subsets containing different B-AR density. Myometrium exhibits homogeneous receptor
density at term (Breuiller and others 1987) but may lose B-ARs during culture preparation.
This phenomenon may be independent from the binding preparation (intact cell or
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membrane preparation) and the location o f the receptor (cellular membrane receptor or
intracellular receptor). A similar loss of intracellular estrogen receptor occurs at different
times after the intact rabbit uterine myocytes are isolated (Sadovsky and others 1992).
Myometrium B-AR number is decreased by the loss of B,-ARs during disaggregation and
24 hour culture.
While leukocyte B-AR number has not changed after three days of incubation,
isoproterenol-, A1F/-, forskolin- and PGEj-stimulated cAMP production are each
significantly decreased. The similar percentage decrease in basal and stimulated cAMP
production suggests that a later step of the cAMP production pathway is depressed. The
nature o f the intracellular change leading to the loss of cAMP production capability in
cultured leukocytes was not established, but does not involve either thyroid hormone,
insulin, human serum, or attachment of a subpopulation of leukocytes to the culture flask.
B-AR coupling to cAMP production does not change during cell isolation and
culture. The inability of B-ARs to couple cAMP production is maintained from fresh
myometrium to myometrial cells cultured for 24 hours. In leukocytes, isoproterenolstimulated cAMP production decreased after three days of culture (Fig. 6). However, the
same percentage stimulation from basal to maximum cAMP level was obtained in fresh
and cultured leukocytes (Fig. 13). These results indicate that the efficacy o f B-AR
coupling to cAMP production has not changed during the isolation or culture process for
either leukocytes or myometrial cells. Furthermore, the loss in B-AR coupled cAMP
production o f cultured myometrial cells may provide a model in studying the cause of
receptor coupling changes at the end of pregnancy.
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In summary, cultured leukocytes and myometrial cells contain similar amounts of
B-ARs capable of stimulation by isoproterenol, with reserve adenylyl cyclase activity not
stimulated by B-AR. Down-regulation occurs following three days exposure to 200 nM
terbutaline and is independent from adenylyl cyclase and PGE,-stimulated cAMP
production. Cultured myometrial cells have higher basal cAMP production than
leukocytes, but cultured leukocytes have higher potency in receptor coupling to cAMP
production. Cultured myometrial cells have a low level of coupling to cAMP production
not present in fresh tissue. B-AR coupling to cAMP production is maintained in both
cultured leukocytes and myometrial cells. Isoproterenol produces relaxation o f term
human myometrium through B2-adrenoceptors. cAMP production is not determined by the
number of B-ARs in myometrium, nor does it reflect myometrial relaxation. Fresh
leukocytes have similar receptor density as cultured leukocytes, but cultured leukocytes
contain less adenylyl cyclase activity.
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CHAPTER 5
SUMMARY AND CONCLUSIONS

1. Human mononuclear leukocytes require the presence of Ca2+ and Mg2* during
isolation to maintain AC activity. Freshly isolated leukocytes have similar B-AR density as
cultured leukocytes, but have higher basal and stimulated adenylyl cyclase activities.

2. Cultured myometrial cells contain a pure population of smooth muscle cells. During
the isolation and culture of myometrial cells, B2-ARs, but not B,-ARs, are lost.

3. B-ARs in cultured human mononuclear leukocytes and myometrial cells have similar
I25I-iodopindolol binding affinity and receptor density. Both tissues can be stimulated by
isoproterenol, but contain additional adenylyl cyclase activity not stimulated by B-ARs.
Basal cAMP production as a percentage of isoproterenol-stimulated cAMP production is
maintained from fresh tissue to cultured cells.

4. Cultured human myometrial cells have higher basal AC activity than leukocytes.
Leukocytes have higher isoproterenol-coupled cAMP production than myometrial cells.

5. The rank order of B-AR agonist potencies in fresh leukocytes is: isoproterenol >
terbutaline > ritodrine. Myometrial cells could not be stimulated by terbutaline or
ritodrine.
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6. Long-term 200 nM terbutaline exposure causes a decrease o f both B-AR number and
isoproterenol-stimulated cAMP production in cultured leukocytes and myometrial cells.
Signal transduction factors, like AC and the PGEt pathway, are not affected by the downregulation process.

7. Isoproterenol-induced myometrium relaxation at term occurs through B2-ARs and is
cAMP independent.

8. Cultured leukocytes do not completely reflect the activity of B-AR coupled cAMP
production in myometrial cultured cells. In myometrium tissue, the existence o f B-AR does
not guarantee a stimulation of cAMP production, and cAMP is not the only index for
myometrial relaxation at the end of pregnancy. While leukocytes may accurately reflect
changes in myometrial B-adrenoceptors, postreceptor differences suggest that they are not
a reasonable indicator o f myometrial relaxation in response to B-AR stimulation.
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